PHIO

#5181
Phio Pharmaceuticals Corp. - Common Stock
0.0 1 USD
-99.03%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.01
0.01
Range Annuel
0.01
1.35
Changement quotidien
-99.03%
Changement Mensuel
-99.08%
Evolution sur 6 mois
-99.07%
Changement Annuel
-99.07%
Clôture Précédente
1.1 4
Open
0.0 1
Low
0.0 1
High
0.0 1
Volume
5
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202020212022202320242025

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

Nouvelles